Literature DB >> 24300135

Preoperative statins and limb salvage after lower extremity revascularization in the Medicare population.

Todd R Vogel1, Viktor Y Dombrovskiy, Edgar Luis Galiñanes, Robin L Kruse.   

Abstract

BACKGROUND: Statins stabilize atherosclerotic plaque, decrease mortality after surgical procedures, and are linked to anti-inflammatory effects. The objective of this study was to evaluate preoperative administration of statins and longitudinal limb salvage after lower extremity endovascular revascularization and lower extremity open surgery. METHODS AND
RESULTS: Patients were selected from 2007 to 2008 Medicare claims using the International Classification of Diseases, Ninth Revision, Clinical Modification, diagnosis codes for claudication (N=8128), rest pain (N=3056), and ulceration/gangrene (N=11,770) and Current Procedural Terminology codes for endovascular revascularization (N=14,353) and open surgery (N=8601). Half (N=11,687) were identified as statin users before revascularization using Part D files. Amputations were identified using Current Procedural Terminology codes. Statin users compared with nonusers had lower amputation rates at 30 days (11.5% versus 14.4%; P<0.0001), 90 days (15.5% versus 19.3%; P<0.0001), and 1 year (20.9% versus 25.6%; P<0.0001). Survival analysis demonstrated improved limb salvage during 1 year for statin users compared with nonusers for the diagnosis of claudication (P=0.003), a similar trend for rest pain (P=0.061), and no improvement for ulceration/gangrene (P=0.65).
CONCLUSIONS: Preoperative statins were associated with improved 1-year limb salvage after lower extremity revascularization. The strongest association was found for patients with the diagnosis of claudication. Statins seem to be underused among Medicare patients with peripheral artery disease. Further evaluation of the use of preoperative statins and the potential benefits for peripheral vascular interventions is warranted.

Entities:  

Keywords:  amputations; survival analysis; vascular surgical procedures

Mesh:

Substances:

Year:  2013        PMID: 24300135     DOI: 10.1161/CIRCINTERVENTIONS.113.000274

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  10 in total

1.  Effect of statins on early and late clinical outcomes of carotid endarterectomy and the rate of post-carotid endarterectomy restenosis.

Authors:  Ali F AbuRahma; Mohit Srivastava; Patrick A Stone; Bryan K Richmond; Zachary AbuRahma; Will Jackson; L Scott Dean; Albeir Y Mousa
Journal:  J Am Coll Surg       Date:  2014-12-15       Impact factor: 6.113

Review 2.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

3.  Sex Differences in Management and Outcomes of Critical Limb Ischemia in the Medicare Population.

Authors:  Amgad Mentias; Mary Vaughan-Sarrazin; Marwan Saad; Saket Girotra
Journal:  Circ Cardiovasc Interv       Date:  2020-10-20       Impact factor: 6.546

Review 4.  Primary and Novel Lipid-Lowering Therapies to Reduce Risk in Patients With Peripheral Arterial Disease.

Authors:  Alicia Chionchio; Andrew Galmer; Benjamin Hirsh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-12-17

5.  Management of Critical Limb Ischemia.

Authors:  Scott Kinlay
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

6.  Endovascular Versus Open Revascularization for Peripheral Arterial Disease.

Authors:  Jason T Wiseman; Sara Fernandes-Taylor; Sandeep Saha; Jeffrey Havlena; Paul J Rathouz; Maureen A Smith; K Craig Kent
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

Review 7.  Critical limb ischemia: current approach and future directions.

Authors:  Kanwar P Singh; Aditya M Sharma
Journal:  J Cardiovasc Transl Res       Date:  2014-05-15       Impact factor: 4.132

8.  Effects of levothyroxine replacement therapy on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients: a prospective pilot study.

Authors:  Zoran Gluvic; Emina Sudar; Jelena Tica; Aleksandra Jovanovic; Sonja Zafirovic; Ratko Tomasevic; Esma R Isenovic
Journal:  Int J Endocrinol       Date:  2015-03-02       Impact factor: 3.257

Review 9.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

10.  Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.

Authors:  Nikhil Singh; Li Ding; Justin Devera; Gregory A Magee; Parveen K Garg
Journal:  JAMA Netw Open       Date:  2021-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.